http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study
( Moon Haeng Hur ),( Dong Hyeon Lee ),( Jeong-hoon Lee ),( Mi-sook Kim ),( Jeayeon Park ),( Hyunjae Shin ),( Sung Won Chung ),( Hee Jin Cho ),( Min Kyung Park ),( Heejoon Jang ),( Yun Bin Lee ),( Su J 대한간학회 2023 춘·추계 학술대회 (The Liver Week) Vol.2023 No.1
Moon Haeng Hur,Yuri Cho,Do Young Kim,Jae Seung Lee,Gyoung Min Kim,Hyo-Cheol Kim,Dong Hyun Sinn,Dongho Hyun,Han Ah Lee,Yeon Seok Seo,In Joon Lee,Joong-Won Park,Yoon Jun Kim 대한간학회 2023 Clinical and Molecular Hepatology(대한간학회지) Vol.29 No.3
Background/Aims: Transarterial radioembolization (TARE) has shown promising results in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). However, whether TARE can provide superior or comparable outcomes to tyrosine kinase inhibitor (TKI) in patients with HCC and PVTT remains unclear. We compared the outcomes of TARE and TKI therapy in treatment-naïve patients with locally advanced HCC and segmental or lobar PVTT. Methods: This multicenter study included 216 patients initially treated with TARE (n=124) or TKI (sorafenib or lenvatinib; n=92) between 2011 and 2021. Baseline characteristics were balanced using propensity score matching (PSM) or inverse probability of treatment weighting (IPTW). The primary outcome was overall survival (OS). The secondary outcomes included progression-free survival (PFS) and objective response rate (ORR). Results: In the unmatched cohort, the median OS of the TARE and TKI groups were 28.2 and 7.2 months, respectively (P<0.001), and the TARE group experienced significantly and independently longer OS compared to the TKI group (adjusted hazard ratio=0.41, 95% confidence interval=0.28–0.60, P<0.001). Similar results were observed in the study cohorts balanced with IPTW (P=0.003) or PSM (P=0.004). Although PFS was comparable between the two groups, the TARE group showed a trend of prolonged PFS in a subpopulation of patients with Vp1 or Vp2 PVTT (P=0.052). In the matched cohorts, the ORR of the TARE group was 53.0–56.7%, whereas that of the TKI group was 12.3–15.0%. Conclusions: For patients with advanced HCC with segmental or lobar PVTT and well-preserved liver function, TARE may provide superior OS compared to sorafenib or lenvatinib.
Genomic Landscape of Non-Hodgkin Lymphoma Patients with Current or Past Hepatitis B Virus Infections
( Moon Haeng Hur ),( Jeayeon Park ),( Youngsu Park ),( Yunmi Ko ),( Hyunjae Shin ),( Yun Bin Lee ),( Eun Ju Cho ),( Jeong-hoon Lee ),( Yoon Jun Kim ),( Jung-hwan Yoon ),( Su Jong Yu ) 대한간학회 2024 춘·추계 학술대회 (The Liver Week) Vol.2024 No.1
데이터마이닝을 이용한 침입 탐지 시스템의 경보데이터 축약기법
허문행(Hur, Moon-Haeng) 한국산학기술학회 2009 한국산학기술학회 학술대회 Vol.- No.-
이 논문에서는 데이터마이닝의 클러스터링을 이용한 경보 데이터 축약기법을 제안한다. 제안된 클러스터링 기반 경보데이터 축약기법은 데이터간의 유사성을 이용한 경보 데이터의 그룹화를 통해 생성된 모델을 이용하여 새로운 경보 데이터에 대한 분류를 자동화할 수 있다. 이것은 과거에 탐지된 공격의 형태뿐만 아니라 새로운 혹은 변형된 경보의 분류나 분석에도 이용할 수 있다. 또한 생성된 클러스터의 생성 원인의 분석을 이용한 클러스터 간의 시퀀스의 추출을 통해 사용자가 공격의 순차적인 구조나 그 이면에 감추어진 전략을 이해하는데 도움을 주며, 현재의 경보 이후에 발생 가능한 경보들을예측할 수 있다.